Sponsor Improves Patient Recruitment in Rare Disease Clinical Trial

Downloadable Case Study

A Mid-sized Sponsor Increased Site Count by 50% in a Rare Disease Clinical Trial with Medidata Acorn AI Intelligent Trials

As they embarked on an upcoming rare disease clinical trial, a mid-sized biopharmaceutical company was struggling with clinical trial patient recruitment and site selection. Between 2016 and 2020, over a quarter of rare disease trials were terminated due to low patient accrual rates. In such a challenging indication, it was critical for this mid-sized sponsor to choose high-performing trial sites based on reliable data to set their trial up for success.

Download this case study to see how Acorn AI helped this sponsor with:

  • Site recommendations based on the sponsor’s key priority metrics, including operational performance
  • Robust data quality metrics
  • A comparison of their historical performance benchmarked against the industry